PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.18%
Negative revenue growth while ADI stands at 1.68%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-54.96%
Negative gross profit growth while ADI is at 1.29%. Joel Greenblatt would examine cost competitiveness or demand decline.
23.89%
EBIT growth 1.25-1.5x ADI's 17.65%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
23.89%
Operating income growth 1.25-1.5x ADI's 17.65%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
5.19%
Net income growth under 50% of ADI's 15.71%. Michael Burry would suspect the firm is falling well behind a key competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.97%
Share change of 1.97% while ADI is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.97%
Diluted share change of 1.97% while ADI is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-10.10%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-70.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-120.49%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
36.26%
10Y revenue/share CAGR under 50% of ADI's 80.93%. Michael Burry would suspect a lasting competitive disadvantage.
10.62%
5Y revenue/share CAGR under 50% of ADI's 45.77%. Michael Burry would suspect a significant competitive gap or product weakness.
9.60%
3Y revenue/share CAGR under 50% of ADI's 45.21%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.27%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
616.08%
10Y net income/share CAGR of 616.08% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-18.38%
Negative 5Y net income/share CAGR while ADI is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
456.75%
Below 50% of ADI's 966.01%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.07%
Negative 3Y equity/share growth while ADI is at 12.33%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
33.94%
Dividend/share CAGR of 33.94% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-18.09%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.28%
AR growth well above ADI's 4.83%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.50%
Inventory growth well above ADI's 4.14%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.75%
Asset growth above 1.5x ADI's 3.22%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.80%
50-75% of ADI's 2.53%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-2.91%
We’re deleveraging while ADI stands at 13.64%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
0.30%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.